Novel synthetic process and formulation development of ELIGLUSTAT tartrate for treatment of GD-1
Temp 1
DST
June 6, 2023
None
None
Gaucher disease type 1
In vitro study
Quantitative data
• Proposing shortest route with two innovative steps to complete the synthesis of Eligustat molecule
Eliglustat tartrate, gaucher disease type-1, photocatalytic
None
None
Dr. Y. V. Madhavi/None/NIPER Hyderabad